NM_001372051.1:c.-27+1372A>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001372051.1(CASP8):c.-27+1372A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.958 in 152,202 control chromosomes in the GnomAD database, including 70,141 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.96   (  70140   hom.,  cov: 31) 
 Exomes 𝑓:  1.0   (  1   hom.  ) 
Consequence
 CASP8
NM_001372051.1 intron
NM_001372051.1 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.700  
Publications
4 publications found 
Genes affected
 CASP8  (HGNC:1509):  (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008] 
CASP8 Gene-Disease associations (from GenCC):
- autoimmune lymphoproliferative syndrome type 2BInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.991  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CASP8 | NM_001372051.1 | c.-27+1372A>G | intron_variant | Intron 1 of 8 | ENST00000673742.1 | NP_001358980.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.958  AC: 145716AN: 152082Hom.:  70091  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
145716
AN: 
152082
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  1.00  AC: 2AN: 2Hom.:  1  Cov.: 0 AF XY:  1.00  AC XY: 2AN XY: 2 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
2
AN: 
2
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
2
AN XY: 
2
show subpopulations 
African (AFR) 
AC: 
0
AN: 
0
American (AMR) 
AC: 
0
AN: 
0
Ashkenazi Jewish (ASJ) 
AC: 
0
AN: 
0
East Asian (EAS) 
AC: 
0
AN: 
0
South Asian (SAS) 
AC: 
0
AN: 
0
European-Finnish (FIN) 
AC: 
0
AN: 
0
Middle Eastern (MID) 
AC: 
0
AN: 
0
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
2
Other (OTH) 
AC: 
0
AN: 
0
GnomAD4 genome  0.958  AC: 145821AN: 152200Hom.:  70140  Cov.: 31 AF XY:  0.960  AC XY: 71436AN XY: 74410 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
145821
AN: 
152200
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
71436
AN XY: 
74410
show subpopulations 
African (AFR) 
 AF: 
AC: 
35709
AN: 
41486
American (AMR) 
 AF: 
AC: 
15008
AN: 
15284
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3463
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
5189
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
4797
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
10597
AN: 
10598
Middle Eastern (MID) 
 AF: 
AC: 
286
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
67824
AN: 
68030
Other (OTH) 
 AF: 
AC: 
2036
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 278 
 556 
 834 
 1112 
 1390 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 910 
 1820 
 2730 
 3640 
 4550 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
3444
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.